Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

Research ArticleADULT BRAIN

Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment

Y. Inoue, M. Nakajima, H. Uetani, T. Hirai, M. Ueda, M. Kitajima, D. Utsunomiya, M. Watanabe, M. Hashimoto, M. Ikeda, Y. Yamashita and Y. Ando
American Journal of Neuroradiology February 2016, 37 (2) 223-227; DOI: https://doi.org/10.3174/ajnr.A4496
Y. Inoue
aFrom the Departments of Neurology (Y.I., M.N., M.U., M.W., Y.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Nakajima
aFrom the Departments of Neurology (Y.I., M.N., M.U., M.W., Y.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Uetani
bDiagnostic Radiology (H.U., T.H., M.K., D.U., Y.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Hirai
bDiagnostic Radiology (H.U., T.H., M.K., D.U., Y.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T. Hirai
M. Ueda
aFrom the Departments of Neurology (Y.I., M.N., M.U., M.W., Y.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kitajima
bDiagnostic Radiology (H.U., T.H., M.K., D.U., Y.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Utsunomiya
bDiagnostic Radiology (H.U., T.H., M.K., D.U., Y.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Watanabe
aFrom the Departments of Neurology (Y.I., M.N., M.U., M.W., Y.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Hashimoto
cPsychiatry and Neuropathobiology (M.H., M.I.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ikeda
cPsychiatry and Neuropathobiology (M.H., M.I.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Yamashita
bDiagnostic Radiology (H.U., T.H., M.K., D.U., Y.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Ando
aFrom the Departments of Neurology (Y.I., M.N., M.U., M.W., Y.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Because the diagnostic significance of cortical superficial siderosis for Alzheimer disease and the association between cortical superficial siderosis and the topographic distribution of cerebral microbleeds have been unclear, we investigated the association between cortical superficial siderosis and clinicoradiologic characteristics of patients with cognitive impairment.

MATERIALS AND METHODS: We studied 347 patients (217 women, 130 men; mean age, 74 ± 9 years) who visited our memory clinic and underwent MR imaging (3T SWI). We analyzed the association between cortical superficial siderosis and the topographic distribution of cerebral microbleeds plus clinical characteristics including types of dementia. We used multivariate logistic regression analysis to determine the diagnostic significance of cortical superficial siderosis for Alzheimer disease.

RESULTS: Twelve patients (3.5%) manifested cortical superficial siderosis. They were older (P = .026) and had strictly lobar cerebral microbleeds significantly more often than did patients without cortical superficial siderosis (50.0% versus 19.4%, P = .02); the occurrence of strictly deep and mixed cerebral microbleeds, however, did not differ in the 2 groups. Alzheimer disease was diagnosed in 162 (46.7%) patients. Of these, 8 patients (4.9%) had cortical superficial siderosis. In the multivariate logistic regression analysis for the diagnosis of Alzheimer disease, lacunar infarcts were negatively and independently associated with Alzheimer disease (P = .007).

CONCLUSIONS: Although cortical superficial siderosis was associated with a strictly lobar cerebral microbleed location, it was not independently associated with Alzheimer disease in a memory clinic setting. Additional studies are required to investigate the temporal changes of these cerebral amyloid angiopathy–related MR imaging findings.

ABBREVIATIONS:

AD
Alzheimer disease
CAA
cerebral amyloid angiopathy
cSS
cortical superficial siderosis
DLB
dementia with Lewy bodies
MBs
cerebral microbleeds
MCI
mild cognitive impairment

Cortical superficial siderosis (cSS) is characterized by linear hypointensities on the surface of cerebral cortex gyri on T2*-weighted gradient-echo MR imaging or SWI.1,2 cSS reflects subtle hemorrhages from amyloid-affected fragile cortical or leptomeningeal vessels and occurs often in patients with cerebral amyloid angiopathy (CAA); associations of cSS with repeat lobar hemorrhages have been reported.3⇓–5 Several studies showed that patients with cognitive impairment manifested a higher prevalence of cSS compared with the general population.6,7 cSS, along with lobar cerebral microbleeds (MBs), was described as a characteristic neuroimaging marker of CAA.8,9

Alzheimer disease (AD) is the most common cause of dementia in the elderly, and CAA is assumed to have a pivotal function in the underlying pathogenesis of AD.10 In the aforementioned studies, cSS was associated with the presence of MBs, and the authors speculated that a relatively high prevalence of cSS in patients with AD indicates this pathogenesis.6,7 We therefore hypothesized that cSS itself may be a significant diagnostic marker of AD and that lobar MBs would be observed more frequently in patients with cSS than in patients without cSS.

The primary aim of the present study was thus to clarify the diagnostic significance of cSS for AD, with the secondary aim being to explore the radiologic markers of small-vessel disease in relation to cSS in patients with cognitive impairment.

Materials and Methods

Study Population

This study consisted of a subanalysis of a prospective clinicoradiologic study described previously.11 Consecutive patients who attended the Dementia Clinic of the Department of Neuropsychiatry, Kumamoto University Hospital, were recruited prospectively from January 2008 to February 2010. The Ethics Committee of Kumamoto University Hospital approved this study. The patients received information about the purpose and method of the study, and written informed consent for participation in the study was obtained from them or their caregivers.

Patients with cognitive impairment associated with posttraumatic brain injury, brain tumor, idiopathic normal pressure hydrocephalus, history of psychiatric diseases or substance abuse, and neurodegenerative diseases, including Pick disease, corticobasal degeneration, and spinocerebellar degeneration, were excluded from this study. Patients whose MR images had severe motion artifacts and patients who did not provide informed consent were also excluded.

All patients received independent neuropsychological evaluations conducted by 2 neuropsychiatrists (M.I., M.H.). Neuropsychological tests including the Mini-Mental State Examination, brain MR imaging, and SPECT were used for diagnosing dementia. Diagnostic criteria included the following: for AD, criteria from the National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer Disease and Related Disorders Association12; for vascular dementia, criteria from the National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherche et l'Enseignement en Neurosciences13; for mild cognitive impairment (MCI), general criteria from the International Working Group on Mild Cognitive Impairment14; for dementia with Lewy bodies (DLB), clinical criteria from the Consortium on Dementia with Lewy Bodies15; and for frontotemporal lobar dementia, the Lund-Manchester criteria for behavioral variant frontotemporal lobar dementia, semantic dementia, or progressive nonfluent aphasia.16 If results of all clinical investigations were normal, patients were classified in a subgroup labeled “subjective memory symptoms.”

MR Imaging Protocol

MR imaging was performed with a 3T whole-body system (Magnetom Trio; Siemens, Erlangen, Germany). Axial SWI, axial FLAIR, axial T2-weighted turbo spin-echo sequences, 3D T1-weighted magnetization-prepared rapid acquisition of gradient echo sequences, diffusion-weighted imaging, MR spectroscopy, and MRA were performed by using the same section thickness, matrix, and parameters as described previously.11

Evaluation of cSS and Other Radiologic Data

We defined cSS as linear hypointensities on the surface of cerebral cortex gyri on SWI; cSS related to previous symptomatic subarachnoid hemorrhage, traumatic subdural hematoma, or intracranial surgery was not included. cSS was classified as focal (restricted to 3 sulci) or disseminated (≥4 sulci).

We defined MBs as small (<10 mm in diameter), homogeneous, round foci of low signal intensity. We excluded symmetric hypointensities in the globi pallidi and dentate nuclei, which we identified as physiologic calcifications or iron deposits; we also excluded hypointense signals inside a lesion that were consistent with infarcts. Lacunar infarcts and white matter hyperintensities were defined according to criteria reported previously.11,17,18 The distribution of MBs was categorized as lobar (frontal, temporal, parietal, and occipital) or deep (thalamoganglionic, brain stem, and cerebellum).

Patients with MBs were divided into 3 groups according to the microbleed distribution. The strictly lobar group had MBs localized exclusively in the lobar region. The strictly deep group had MBs located only in the thalamoganglionic and infratentorial regions. The mixed group had MBs throughout both lobar and deep regions. All radiologic findings were assessed by 2 experienced neuroradiologists (H.U., T.H.) who were blinded to the clinical information.

Clinical Data Collection

Baseline clinical information, including age, sex, history of hypertension, length of education, and Mini-Mental State Examination results, was recorded at registration. Hypertension was defined as a history of hypertension or prescription of antihypertensive medications.

Statistical Analyses

We compared baseline demographics and clinical characteristics for patients with any cSS and patients with no cSS. Categoric data were evaluated by using the χ2 test and the Fisher 2-tailed exact test. Continuous variables were compared by using the Mann-Whitney U test. We next conducted multivariate logistic regression analysis to investigate the predictors for diagnosing AD. The independent variables included age, sex, hypertension, length of education, distribution of MBs (strictly lobar, strictly deep, or mixed), lacunar infarcts, white matter hyperintensities, and cSS. Backward stepwise logistic regression analysis was performed by adjusting for age,19⇓–21 sex,22 length of education,23 and variables that were automatically selected in a backward stepwise selection method. We performed a backward selection procedure for each outcome by using P > .10 of the likelihood ratio test for exclusion of variables. The OR and 95% CI were obtained. The statistical significance level was set at P < .05. In addition, we calculated the sensitivity, specificity, positive predictive value, and negative predictive value of cSS for the clinical diagnosis of AD. Statistical analyses were performed by using JMP 9.0 statistical software (SAS Institute, Cary, North Carolina).

Results

Prevalence of cSS

A total of 347 patients (217 women, 130 men; mean age, 74 ± 9 years) with cognitive impairment visited our hospital from January 2008 to February 2010. Of these patients, 12 (3.5%) had cSS.

Clinical Characteristics Related to cSS

Table 1 provides demographic and clinical characteristics of the patients. Patients with cSS were older (P = .026) compared with patients without cSS. No significant differences were observed in the occurrence of cSS across different types of dementia (P = .337), and a bivariate analysis also demonstrated no differences between patients with and without AD (P = .239). Sensitivity, specificity, positive predictive value, and negative predictive value of cSS for the clinical diagnosis of AD were 4.9%, 97.8%, 66.7%, and 54.0%, respectively (4 patients had cSS but no AD, 8 patients had both cSS and AD, 181 patients had no cSS or AD, and 154 patients had AD but no cSS).

View this table:
  • View inline
  • View popup
Table 1:

Demographic and clinical characteristics of patients with or without cSS

Location and Topographic Distribution of MBs

Strictly lobar MBs were observed more frequently in patients with cSS than in patients without cSS (P = .020), whereas the 2 groups did not differ with regard to the occurrence of strictly deep MBs (P = 1.00) and mixed MBs (P = .154). MBs in each cerebral lobe (frontal [P = .003], temporal [P < .001], parietal [P = .007], and occipital [P = .002]) had a significant association with the presence of cSS. However, patients with cSS and those without cSS showed no significant differences in the presence of thalamoganglionic MBs (P = .456), brain stem MBs (P = .088), and cerebellar MBs (P = .222) (Table 2). We also performed a separate analysis of demographic and clinicoradiologic characteristics in patients with AD and found similar tendencies in location and topographic distribution of MBs for that whole population (On-line Table). Among patients with AD, strictly lobar MBs were observed more frequently in patients with cSS than in patients without cSS (P = .004). MBs in each cerebral lobe (frontal [P = .040], temporal [P < .001], parietal [P = .040], and occipital [P = .006]) also had a significant association with the presence of cSS.

View this table:
  • View inline
  • View popup
Table 2:

Radiologic characteristics of patients with or without cSS

Clinicoradiologic Characteristics of Patients with cSS

We further investigated the clinicoradiologic characteristics of 12 patients with cSS (6 women, 6 men; mean age, 79 ± 5 years) (Table 3). Of these, AD was diagnosed in 8 patients (66.7%); DLB, in 1 patient (8.3%); vascular dementia, in 1 patient (8.3%); and MCI, in 2 patients (16.7%). cSS was observed in 22 cerebral lobes, and its location corresponded to locations of MBs in 13 lobes (72.2%). We noted a tendency of cSS to occur in temporal and occipital lobes, and the distribution was focal in 7 patients (58.3%) and disseminated in 5 patients (41.7%). Six patients (50%) had strictly lobar MBs, 5 patients (41.7%) had mixed MBs, no patient with cSS had strictly deep MBs, and 1 patient (8.3%) had no MBs (case 2, Table 3). Four patients (33.3%) were classified as having grade 1 white matter hyperintensities; 5 patients (41.7%), grade 2 white matter hyperintensities; and 3 patients (25.0%), grade 3 white matter hyperintensities. No correlations between age-related white matter change rating scores and the location of cSS were found.

View this table:
  • View inline
  • View popup
Table 3:

Clinicoradiologic characteristics of patients with cSS

Relationship among cSS, MBs, and AD

Table 4 shows the results of multivariate logistic regression analysis for the diagnosis of AD. In the multivariate model, lacunar infarcts (OR, 0.46; 95% CI, 0.25–0.81; P = .007) were negatively and independently associated with AD, and the presence of cSS was not associated with AD (OR, 2.99; 95% CI, 0.88–12.0; P = .08).

View this table:
  • View inline
  • View popup
Table 4:

Multivariate logistic regression analysis for ADa

Discussion

This study is the first to investigate the diagnostic significance of cSS for AD and the relationships between cSS and the location of MBs in patients with cognitive impairment. The major new finding was that patients with cSS had strictly lobar MBs significantly more often than patients without cSS.

With respect to spatial distributions of MBs, past histopathologic studies of patients with intracerebral hemorrhage revealed that strictly lobar MBs strongly suggested CAA.24 The population-based Rotterdam Scan Study showed a tendency for MBs to be located in the lobar region, especially in the temporal lobes.25 A case-control and memory clinic–based cross-sectional study including patients with AD showed that the microbleed topography was significantly predominant in the occipital region.26 Our study indicated that strictly lobar MBs are closely related to cSS, which was shown to be a marker of CAA. This tendency also persisted among patients with AD with or without cSS, 2 groups who were barely distinguishable from each other except for a higher prevalence of a lobar microbleed location in patients with AD and cSS.

With respect to the diagnostic significance of cSS for AD, though AD was diagnosed in most patients with cSS, multivariate logistic regression analysis showed that neither cSS nor MBs in any location were independent significant predictors for the diagnosis of AD. An explanation of this result is that CAA pathogenesis also occurs in patients with dementias other than AD. Other histopathologic studies reported CAA in patients with DLB and vascular dementia and a low prevalence of CAA in patients with frontotemporal lobar dementia.27⇓–29 MCI was reportedly a transitional state of AD,30 so our patients with cognitive impairment may have had CAA pathologic features. Thus, the similar occurrence of cSS and pathologic findings of CAA in patients with cognitive impairment again indicated the same underlying pathophysiologic mechanisms.

As an interesting finding, 1 female patient had AD and cSS without MBs in the present study, whereas all other patients manifested both cSS and MBs. As with convexity subarachnoid hemorrhage, cSS has causes other than CAA: posterior reversible leukoencephalopathy syndrome, reversible cerebral vasoconstriction syndrome, and lupus vasculitis.31 One study indicated that cSS or convexity subarachnoid hemorrhage does not always reflect CAA pathogenesis.31 Given the older age and impaired cognition of our patients, however, most cSS in our study presumably resulted from CAA, as in another study that found CAA in >80% of patients with AD.32 A cross-sectional study including patients with probable or definite CAA, diagnosed on the basis of the Boston criteria,33 found inverse associations among the severity of cSS, number of MBs, and apolipoprotein E ε4.34 These authors also speculated that cSS may arise from vasculopathic mechanisms different from those associated with CAA-related microbleeds.34 Because this patient in our study had no history of possible underlying causes of cSS other than CAA, cSS may have manifested as an initial radiologic finding of CAA.

Limitations of the present study included using a relatively small population and a heterogeneous patient population without AD (DLB, frontotemporal lobar dementia, vascular dementia, MCI, and subjective symptoms) as a reference group in the multivariate logistic regression analysis.

Our study results indicated that cSS was associated with a lobar location of MBs and may be an initial radiologic finding of CAA in patients with cognitive impairment. Additional prospective studies to investigate temporal changes of these CAA-related MR imaging findings may help in understanding the mechanisms of cognitive decline.

Conclusions

The prevalence of cSS was 3.9% in our memory clinic. Most patients with cSS were diagnosed as having AD, and the specificity of cSS for the clinical diagnosis of AD was high. Strictly lobar MBs were observed more frequently in patients with cSS than in patients without cSS.

Footnotes

  • Disclosures: Mitsuharu Ueda—UNRELATED: Grants/Grants Pending: Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25870541).* Manabu Ikeda—UNRELATED: Grants/Grants Pending: Daiichi Sankyo,* Eisai,* FUJIFILM RI,* Janssen Pharmaceuticals,* Nihon Medi-Physics,* Novartis,* Pfizer,* Takeda,* Tsumura,* Comments: as the chairman of the department; Payment for Lectures (including service on Speakers Bureaus): Daiichi Sankyo, Eisai, FUJIFILM RI, Janssen Pharmaceuticals, Nihon Medi-Physics, Novartis, Pfizer, Takeda, Tsumura, MSD, Ono Pharmaceutical. *Money paid to the institution.

References

  1. 1.↵
    1. Kumar N
    . Neuroimaging in superficial siderosis: an in-depth look. AJNR Am J Neuroradiol 2010;31:5–14 doi:10.3174/ajnr.A1628 pmid:19729538
    Abstract/FREE Full Text
  2. 2.↵
    1. Linn J,
    2. Herms J,
    3. Dichgans M, et al
    . Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 2008;29:184–86 doi:10.3174/ajnr.A0783 pmid:17947366
    Abstract/FREE Full Text
  3. 3.↵
    1. Feldman HH,
    2. Maia LF,
    3. Mackenzie IR, et al
    . Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 2008;39:2894–97 doi:10.1161/STROKEAHA.107.510826 pmid:18635858
    Abstract/FREE Full Text
  4. 4.↵
    1. Linn J,
    2. Wollenweber FA,
    3. Lummel N, et al
    . Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 2013;260:176–81 doi:10.1007/s00415-012-6610-7 pmid:22820723
    CrossRefPubMed
  5. 5.↵
    1. Charidimou A,
    2. Peeters AP,
    3. Jäger R, et al
    . Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013;81:1666–73 doi:10.1212/01.wnl.0000435298.80023.7a pmid:24107862
    Abstract/FREE Full Text
  6. 6.↵
    1. Zonneveld HI,
    2. Goos JD,
    3. Wattjes MP, et al
    . Prevalence of cortical superficial siderosis in a memory clinic population. Neurology 2014;82:698–704 doi:10.1212/WNL.0000000000000150 pmid:24477113
    Abstract/FREE Full Text
  7. 7.↵
    1. Wollenweber FA,
    2. Buerger K,
    3. Mueller C, et al
    . Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol 2014;261:277–82 doi:10.1007/s00415-013-7181-y pmid:24221645
    CrossRefPubMed
  8. 8.↵
    1. Charidimou A,
    2. Gang Q,
    3. Werring DJ
    . Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012;83:124–37 doi:10.1136/jnnp-2011-301308 pmid:22056963
    Abstract/FREE Full Text
  9. 9.↵
    1. Ellis RJ,
    2. Olichney JM,
    3. Thal LJ, et al
    . Cerebral amyloid angiopathy in brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996;46:1592–96 doi:10.1212/WNL.46.6.1592 pmid:8649554
    Abstract/FREE Full Text
  10. 10.↵
    1. Yamada M
    . Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 2002;977:37–44 doi:10.1111/j.1749-6632.2002.tb04797.x pmid:12480732
    CrossRefPubMed
  11. 11.↵
    1. Uetani H,
    2. Hirai T,
    3. Hashimoto M, et al
    . Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia. AJNR Am J Neuroradiol 2013;34:984–89 doi:10.3174/ajnr.A3332 pmid:23124636
    Abstract/FREE Full Text
  12. 12.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M, et al
    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44 doi:10.1212/WNL.34.7.939 pmid:6610841
    Abstract/FREE Full Text
  13. 13.↵
    1. Román GC,
    2. Tatemichi TK,
    3. Erkinjuntti T, et al
    . Vascular dementia: diagnostic criteria for research studies—report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–60 doi:10.1212/WNL.43.2.250 pmid:8094895
    Abstract/FREE Full Text
  14. 14.↵
    1. Winblad B,
    2. Palmer K,
    3. Kivipelto M, et al
    . Mild cognitive impairment beyond controversies—towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–46 doi:10.1111/j.1365-2796.2004.01380.x pmid:15324367
    CrossRefPubMed
  15. 15.↵
    1. McKeith IG,
    2. Galasko D,
    3. Kosaka K, et al
    . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–24 doi:10.1212/WNL.47.5.1113 pmid:8909416
    Abstract/FREE Full Text
  16. 16.↵
    1. Neary D,
    2. Snowden JS,
    3. Gustafson L, et al
    . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54 doi:10.1212/WNL.51.6.1546 pmid:9855500
    Abstract/FREE Full Text
  17. 17.↵
    1. Fazekas F,
    2. Chawluk JB,
    3. Alavi A, et al
    . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763
    CrossRefPubMed
  18. 18.↵
    1. Wahlund LO,
    2. Barkhof F,
    3. Fazekas F, et al
    ; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318–22 doi:10.1161/01.STR.32.6.1318 pmid:11387493
    Abstract/FREE Full Text
  19. 19.↵
    1. Evans DA,
    2. Funkenstein HH,
    3. Albert MS, et al
    . Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551–56 doi:10.1001/jama.1989.03430180093036 pmid:2810583
    CrossRefPubMed
  20. 20.↵
    1. Jorm AF,
    2. Korten AE,
    3. Henderson AS
    . The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465–79 doi:10.1111/j.1600-0447.1987.tb02906.x pmid:3324647
    CrossRefPubMed
  21. 21.↵
    1. Rocca WA,
    2. Amaducci LA,
    3. Schoenberg BS
    . Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986;19:415–24 doi:10.1002/ana.410190502 pmid:3717905
    CrossRefPubMed
  22. 22.↵
    1. Gao S,
    2. Hendrie HC,
    3. Hall KS, et al
    . The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998;55:809–15 doi:10.1001/archpsyc.55.9.809 pmid:9736007
    CrossRefPubMed
  23. 23.↵
    1. Lindsay J,
    2. Laurin D,
    3. Verreault R, et al
    . Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445–53 doi:10.1093/aje/kwf074 pmid:12196314
    Abstract/FREE Full Text
  24. 24.↵
    1. Fazekas F,
    2. Kleinert R,
    3. Roob G, et al
    . Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637–42 pmid:10319975
    Abstract/FREE Full Text
  25. 25.↵
    1. Mesker DJ,
    2. Poels MM,
    3. Ikram MA, et al
    . Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2011;68:656–59 doi:10.1001/archneurol.2011.93 pmid:21555643
    CrossRefPubMed
  26. 26.↵
    1. Shams S,
    2. Martola J,
    3. Granberg T, et al
    . Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis—the Karolinska Imaging Dementia Study. AJNR Am J Neuroradiol 2015;36:661–66 doi:10.3174/ajnr.A4176 pmid:25523590
    Abstract/FREE Full Text
  27. 27.↵
    1. Esiri MM,
    2. Wilcock GK
    . Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 1986;49:1221–26 doi:10.1136/jnnp.49.11.1221 pmid:3794727
    Abstract/FREE Full Text
  28. 28.↵
    1. De Reuck J,
    2. Deramecourt V,
    3. Cordonnier C, et al
    . Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study. J Neurol Sci 2011;300:63–66 doi:10.1016/j.jns.2010.09.031 pmid:20965516
    CrossRefPubMed
  29. 29.↵
    1. De Reuck J,
    2. Deramecourt V,
    3. Cordonnier C, et al
    . Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. Eur J Neurol 2012;19:1355–60 doi:10.1111/j.1468-1331.2012.03776.x pmid:22642502
    CrossRefPubMed
  30. 30.↵
    1. Markesbery WR
    . Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 2010;19:221–28 doi:10.3233/JAD-2010-1220 pmid:20061641
    CrossRefPubMed
  31. 31.↵
    1. Kumar S,
    2. Goddeau RP Jr.,
    3. Selim MH, et al
    . Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010;74:893–99 doi:10.1212/WNL.0b013e3181d55efa pmid:20231664
    Abstract/FREE Full Text
  32. 32.↵
    1. Pettersen JA,
    2. Sathiyamoorthy G,
    3. Gao FQ, et al
    . Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 2008;65:790–95 doi:10.1001/archneur.65.6.790 pmid:18541799
    CrossRefPubMed
  33. 33.↵
    1. Knudsen KA,
    2. Rosand J,
    3. Karluk D, et al
    . Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537–39 doi:10.1212/WNL.56.4.537 pmid:11222803
    Abstract/FREE Full Text
  34. 34.↵
    1. Shoamanesh A,
    2. Martinez-Ramirez S,
    3. Oliveira-Filho J, et al
    . Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology 2014;83:1838–43 doi:10.1212/WNL.0000000000000984 pmid:25320098
    Abstract/FREE Full Text
  • Received January 12, 2015.
  • Accepted after revision June 18, 2015.
  • © 2016 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 37 (2)
American Journal of Neuroradiology
Vol. 37, Issue 2
1 Feb 2016
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Y. Inoue, M. Nakajima, H. Uetani, T. Hirai, M. Ueda, M. Kitajima, D. Utsunomiya, M. Watanabe, M. Hashimoto, M. Ikeda, Y. Yamashita, Y. Ando
Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment
American Journal of Neuroradiology Feb 2016, 37 (2) 223-227; DOI: 10.3174/ajnr.A4496

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer Disease in Patients with Cognitive Impairment
Y. Inoue, M. Nakajima, H. Uetani, T. Hirai, M. Ueda, M. Kitajima, D. Utsunomiya, M. Watanabe, M. Hashimoto, M. Ikeda, Y. Yamashita, Y. Ando
American Journal of Neuroradiology Feb 2016, 37 (2) 223-227; DOI: 10.3174/ajnr.A4496
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Neuroinfectiology of an atypical anthrax-causing pathogen in wild chimpanzees
  • Genetic, transcriptome, proteomic and epidemiological evidence for blood brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimers disease
  • Superficial siderosis misdiagnosed as idiopathic bilateral neurosensorial deafness
  • The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
  • Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population
  • Cortical Superficial Siderosis Presumed due to Cerebral Amyloid Angiopathy: Minimum Standards for Rating and Reporting
  • Cerebral Amyloid Angiopathy as an Etiology for Cortical Superficial Siderosis: An Unproven Hypothesis
  • Reply:
  • Crossref (24)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
    Gargi Banerjee, Roxana Carare, Charlotte Cordonnier, Steven M Greenberg, Julie A Schneider, Eric E Smith, Mark van Buchem, Jeroen van der Grond, Marcel M Verbeek, David J Werring
    Journal of Neurology, Neurosurgery & Psychiatry 2017 88 11
  • The growing clinical spectrum of cerebral amyloid angiopathy
    Marieke J.H. Wermer, Steven M. Greenberg
    Current Opinion in Neurology 2018 31 1
  • Seven-layer deep neural network based on sparse autoencoder for voxelwise detection of cerebral microbleed
    Yu-Dong Zhang, Yin Zhang, Xiao-Xia Hou, Hong Chen, Shui-Hua Wang
    Multimedia Tools and Applications 2018 77 9
  • Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
    Chris J. Carter
    Journal of Alzheimer's Disease Reports 2017 1 1
  • Cortical superficial siderosis
    Sara Shams, Juha Martola, Andreas Charidimou, Lena Cavallin, Tobias Granberg, Mana Shams, Yngve Forslin, Peter Aspelin, Maria Kristoffersen-Wiberg, Lars-Olof Wahlund
    Neurology 2016 87 11
  • Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population
    Bibek Gyanwali, Muhammad Amin Shaik, Narayanaswamy Venketasubramanian, Christopher Chen, Saima Hilal
    Journal of Alzheimer's Disease 2019 71 4
  • Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
    Yasuteru Inoue, Yukio Ando, Yohei Misumi, Mitsuharu Ueda
    International Journal of Molecular Sciences 2021 22 8
  • Susceptibility‐Weighted Imaging in Neurodegenerative Disorders: A Review
    Houman Sotoudeh, Amir Hossein Sarrami, Jian‐xiong Wang, Zahra Saadatpour, Ali Razaei, Siddhartha Gaddamanugu, Gagandeep Choudhary, Omid Shafaat, Aparna Singhal
    Journal of Neuroimaging 2021 31 3
  • Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke
    Satoshi Suda, Takashi Shimoyama, Shizuka Suzuki, Takahiro Ouchi, Masafumi Arakawa, Junya Aoki, Kentaro Suzuki, Yuki Sakamoto, Seiji Okubo, Yasuhiro Nishiyama, Chikako Nito, Masahiro Mishina, Kazumi Kimura
    Journal of Neurology 2017 264 12
  • Increased cerebral microbleeds and cortical superficial siderosis in pediatric patients with Down syndrome
    Franziska Schoeppe, Andrea Rossi, Johannes Levin, Maximilian Reiser, Sophia Stoecklein, Birgit Ertl-Wagner
    European Journal of Paediatric Neurology 2019 23 1

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Segmentation of Brain Metastases with BLAST
  • Cerebral ADC Changes in Fabry Disease
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • AJNR Awards
  • ASNR Foundation Special Collection
  • Most Impactful AJNR Articles
  • Photon-Counting CT
  • Spinal CSF Leak Articles (Jan 2020-June 2024)

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire